Cloning Erlotinib EGFR Inhibitor NSCLC Pancreatic Cancer

Erlotinib is a powerful EGFR blocker often used for treating non-small cell lung cancer and pancreatic cancer caused by EGFR mutations. It works by stopping the EGFR from signaling, which is a big deal in cancer cell growth. This drug comes in tablets with a coating, and you can get it in 25, 100, or 150 mg doses.

Grown-ups usually take 150 mg every day, preferably on an empty stomach so it’s really absorbed. Each bottle has 30 pills, enough for a whole month at the highest dose. Erlotinib stops the EGFR from connecting with its friends, which messes with cell growth and survival.

Clinical trials showed it helps people with lung cancer caused by EGFR mutations, which is why doctors can use it. The most common side effects are feeling sick to your stomach, the runs, throwing up, a skin rash, and being tired all the time. It’s a big deal to keep an eye on your liver and stomach during the whole time you’re taking it.